A war on “prediabetes” has created millions of new patients and a tempting opportunity for pharma. But how real is the condition?
A dangerous virus, as yet unknown, has the potential to wipe out millions of us. Yet public health bodies are mired in complacency.
Health care consumers are contributing their skills, money, and time to develop effective solutions that aren’t available on the commercial market.